Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:MTAC

MedTech Acquisition (MTAC) Stock Price, News & Analysis

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Free MTAC Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$8.96
▼
$12.83
50-Day Range
$9.34
▼
$11.34
52-Week Range
$8.43
▼
$12.83
Volume
183,276 shs
Average Volume
9,656 shs
Market Capitalization
$83.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
MTAC stock logo

About MedTech Acquisition Stock (NASDAQ:MTAC)

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

MTAC Stock News Headlines

May 11, 2024 | markets.businessinsider.com
MedTech Acquisition Corporation Registered Shs hosts conference call for investors
January 23, 2024 | msn.com
Johnson & Johnson’s MedTech performance augurs well for industry: analysts
January 23, 2024 | msn.com
Johnson & Johnson’s earnings beat estimates with boost from medtech sales
November 29, 2023 | forbes.com
5 Tips To Ensure Product-Market Fit In Medtech
November 15, 2023 | bizjournals.com
Westminster oncology company holds first earnings call since going public
November 14, 2023 | finance.yahoo.com
TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update
September 25, 2023 | forbes.com
The Art Of A Profitable Medtech Exit
August 8, 2023 | markets.businessinsider.com
Pre-market Movers: MTAC, AYX, DDOG, IFF, CHGG…
August 3, 2023 | finance.yahoo.com
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders
July 20, 2023 | msn.com
Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform
May 30, 2023 | msn.com
Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
May 10, 2023 | investing.com
LAVA Medtech Acquisition Corp (LVAC)
April 26, 2023 | forbes.com
Six Ways To Lead The Charge In Medtech
April 20, 2023 | finance.yahoo.com
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases
February 21, 2023 | finance.yahoo.com
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business
December 8, 2022 | yahoo.com
MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders
November 16, 2022 | finance.yahoo.com
TriSalus Goes SPAC Way To Fund Pressure-Enabled Drug Delivery Tech Based Cancer Trials
November 14, 2022 | finance.yahoo.com
TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation
August 9, 2022 | finance.yahoo.com
Global MedTech Healthcare IT Industry Competitive Landscape
July 27, 2022 | apnews.com
LSI Emerging Medtech Summit 2022 Brings Venture Capital and Entrepreneurs Closer in New Event in Europe
July 15, 2022 | benzinga.com
Ophthalmic Devices Market is expected to be worth USD 83.1 billion by 2030, with a CAGR of 4.7%.
June 12, 2022 | seekingalpha.com
Medtronic: Stable Growth Ahead
May 31, 2022 | msn.com
3 Med-Tech Stocks With Incredible Potential
May 27, 2022 | seekingalpha.com
Medtronic plc (MDT) CEO Geoff Martha on Q4 2022 Results - Earnings Call Transcript
April 8, 2022 | finance.yahoo.com
MedTech Acquisition Corporation (MTAC)
See More Headlines

Company Calendar

Today
5/20/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:MTAC
CUSIP
N/A
CIK
1826667
Web
N/A
Phone
908-391-1288
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.54 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-17.92%
Return on Assets
-1.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.03
Quick Ratio
0.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.89 per share
Price / Cash Flow
12.80
Book Value
($2.04) per share
Price / Book
-5.56

Miscellaneous

Outstanding Shares
7,390,000
Free Float
1,952,000
Market Cap
$83.80 million
Optionable
Not Optionable
Beta
-0.04

Key Executives

  • Mr. Christopher C. Dewey (Age 79)
    CEO & Director
  • Mr. David J. Matlin J.D. (Age 61)
    CFO & Director
  • Mr. Robert H. Weiss J.D. (Age 64)
    Chief Admin. Officer & Sec.

Key Competitors

View All Competitors

This page (NASDAQ:MTAC) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
4 Cryptos BETTER than Bitcoin
True Market Insiders
Does this make you sick?
Allegiance Gold
Bill Gates is all about this tiny $2 stock
Timothy Sykes
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Shocking: One AI startup's revenue could surge 4,735%
Manward Press